IBX Secures Additional Capital — Shareholders Exercise Options
February 1, 2021
Imagion Biosystems announced on ASX that it has received a total of $267,030. Please click to review the full announcement at ASX.
Category: Investor updates
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
February 1, 2021
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 1 February, 2021. Please click to review the
Quarterly Activity Report for 31 December 2020 — Appendix 4C
January 20, 2021
Imagion Biosystems today released its Appendix 4C Quarterly Cashflow report and update on Company activities for the quarter ending 31 December 2020 (Q4 FY2020). Q4
IBX Secures Additional Capital — Shareholders Exercise Options
January 18, 2021
Imagion Biosystems announces that it has received a total of $369,689.99 for the exercise of options. Please click to review the full announcement at ASX.
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
January 18, 2021
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 18 January, 2021. Please click to review the
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
December 21, 2020
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 21 December, 2020. Please click to review the
IBX Secures Additional Capital — Shareholders Exercise Options
December 21, 2020
Imagion Biosystems announces that it has received a total of $250,540.57 for the exercise of Options. Please click to review the full announcement at ASX.
Imagion Biosystems December 2020 Investor Newsletter
December 16, 2020
Imagion Biosystems is pleased to provide its investors with its December 2020 Investor Newsletter. The newsletter details recent new company developments and activities including: Message from
First In-human Study Update: Study Open for Enrolment
December 15, 2020
Imagion Biosystems is pleased to announce that Monash Health has been established as the first clinical site and is ready to commence enrolment of patients
Issue of Unlisted Performance Options under Equity Incentive Plan
December 14, 2020
The document “Issue of Unlisted Performance Options under Equity Incentive Plan” was lodged with ASX on December 14, 2020. Please click to review the full